Jana Hanzlikova
Pilsen, PL, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling, 2026: International consensus statement on behalf of the European Society for Immunodeficiencies/European Society for Blood and Marrow Transplantation-Inborn Errors Working Party and ERN-RITA.
Journal: The Journal of allergy and clinical immunology
Published: March 09, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.
Journal: The Journal of allergy and clinical immunology
Published: March 09, 2026
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Journal: The Journal of allergy and clinical immunology
Published: July 21, 2023
Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort.
Journal: Journal of clinical immunology
Published: February 23, 2023
Myeloid lineage cells evince distinct steady-state level of certain gene groups in dependence on hereditary angioedema severity.
Journal: Frontiers in genetics
Published: December 14, 2022
Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: February 07, 2022
Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.
Journal: Frontiers in immunology
Published: December 14, 2021
Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.
Journal: Journal of clinical immunology
Published: July 22, 2021
Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients.
Journal: International archives of allergy and immunology
Published: October 02, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
Journal: The Journal of allergy and clinical immunology
Published: June 24, 2020
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 19, 2018
Utility of laboratory testing for the diagnosis of Hymenoptera venom allergy.
Journal: Allergy and asthma proceedings
Published: May 15, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026